Akoya Biosciences Inc (AKYA)
2.90
0.00 (0.00%)
USD |
NASDAQ |
Sep 20, 16:00
2.76
-0.14
(-4.83%)
After-Hours: 20:00
Akoya Biosciences Total Assets (Quarterly): 143.74M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 143.74M |
March 31, 2024 | 154.75M |
December 31, 2023 | 180.37M |
September 30, 2023 | 177.24M |
June 30, 2023 | 188.88M |
March 31, 2023 | 154.30M |
December 31, 2022 | 176.03M |
September 30, 2022 | 176.46M |
Date | Value |
---|---|
June 30, 2022 | 184.26M |
March 31, 2022 | 187.13M |
December 31, 2021 | 190.91M |
September 30, 2021 | 195.41M |
June 30, 2021 | 206.34M |
March 31, 2021 | 74.48M |
December 31, 2020 | 77.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Mar 2021
206.34M
Maximum
Jun 2021
164.53M
Average
177.24M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
Bruker Corp | 5.903B |
Azenta Inc | 2.323B |
Harvard Bioscience Inc | 128.91M |
Bionano Genomics Inc | 129.36M |
Singular Genomics Systems Inc | 220.00M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 121.50M |
Shareholders Equity (Quarterly) | 22.25M |
Debt to Equity Ratio | 3.402 |
Current Ratio | 2.734 |
Net Debt Paydown Yield | -2.11% |